Representative before the EPO

Employment test 51 - 200 employees
Company dna arnold plus siedsma
operating since 1920
Headquarter in The Hague and 13 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna crucell holland bv
no operation time available
1 office
active in Legal Services

We have observed 26 EP applications Annemieke Manten has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12735516

HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA A VIRUSES OF PHYLOGENETIC GROUP 1 AND PHYLOGENETIC GROUP 2 AND INFLUENZA B VIRUSES

IPC classification:
A61K 39/42, C07K 16/10, A61P 31/16
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
PATENT GRANTED
EP12791759

INFLUENZA VIRUS VACCINES AND USES THEREOF

IPC classification:
A61K 39/12, C07K 14/005
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION IN PROGRESS
EP13708411

HUMAN BINDING MOLECULES CAPABLE OF BINDING TO AND NEUTRALIZING INFLUENZA B VIRUSES AND USES THEREOF

IPC classification:
C07K 16/10
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
The patent has been granted
EP13707395

IMPROVED VACCINATION AGAINST INFLUENZA

IPC classification:
A61K 39/145
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
PATENT GRANTED
EP13714231

VACCINE AGAINST RSV

IPC classification:
A61K 39/155, A61P 31/14
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
The patent has been granted
EP13711054

VACCINE AGAINST RSV

IPC classification:
A61K 39/155, A61P 31/14
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
PATENT GRANTED
EP14708064

ACELLULAR PERTUSSIS VACCINE

IPC classification:
A61K 39/02, A61K 39/00
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
PATENT GRANTED
EP14717446

HUMAN ANTIBODIES BINDING TO RSV G PROTEIN

IPC classification:
C07K 14/115, A61K 39/155, C07K 16/10
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION IN PROGRESS
EP14717753

HUMAN ANTIBODIES BINDING TO RSV G PROTEINS

IPC classification:
C07K 14/115, A61K 39/155, C07K 16/10
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION IN PROGRESS
EP14719022

STABILIZED SOLUBLE PREFUSION RSV F POLYPEPTIDES

IPC classification:
C07K 14/135, A61K 39/155
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION REQUESTED
EP14730460

INFLUENZA VIRUS VACCINES AND USES THEREOF

IPC classification:
A61K 48/00, A61K 39/145, C12N 15/79, C12N 15/63, C12N 15/62, C07K 14/11
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION IN PROGRESS
EP14731940

STABILIZED SOLUBLE PRE-FUSION RSV F POLYPEPTIDES

IPC classification:
C07K 14/135
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
The patent has been granted
EP14733650

METHOD FOR PREPARING VIROSOMES

IPC classification:
A61K 39/295, A61K 39/12, A61K 39/145, C12N 7/02
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
The patent has been granted
EP14734798

METHOD FOR PREPARING VIROSOMES

IPC classification:
A61K 9/127, A61K 39/145, A61K 39/12
Applicant:
Crucell Holland B.V.
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
GRANT OF PATENT INTENDED
EP14827180

PROCESS FOR PREPARING INFLUENZA VACCINES

IPC classification:
G01N 33/53, C07K 16/00, A61K 39/00
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION REQUESTED
EP15731934

ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THAT SPECIFICALLY BIND TO MICROTUBULE-ASSOCIATED PROTEIN TAU

IPC classification:
A61K 39/395, C07K 16/18
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION REQUESTED
EP15738028

INFLUENZA VIRUS VACCINES AND USES THEREOF

IPC classification:
A61K 39/145, C07K 14/11
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION REQUESTED
EP15738027

INFLUENZA VIRUS VACCINES AND USES THEREOF

IPC classification:
A61K 39/145, C07K 14/11
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
EXAMINATION REQUESTED
EP16702748

HUMAN NEUTRALIZING ANTIBODIES BINDING TO INFLUENZA NEURAMINIDASE

IPC classification:
C07K 16/10, A61K 39/42, C07K 16/00
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
Request for examination was made
EP16703151

BINDING MOLECULES DIRECTED AGAINST INFLUENZA HEMAGGLUTININ AND USES THEREOF

IPC classification:
A61K 39/00, C07K 16/10, C07K 16/08, C07K 16/12, A61K 39/395
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
Request for examination was made
EP16705157

METHOD FOR QUANTIFICATION OF VIRUS PARTICLES USING CAPILLARY ZONE ELECTROPHORESIS

IPC classification:
G01N 27/447, C12Q 1/70
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Agent:
Annemieke Manten, Crucell Holland B.V.
Status:
Request for examination was made
EP16726798

INFLUENZA VIRUS NEUTRALIZING PEPTIDOMIMETIC COMPOUNDS

IPC classification:
A61P 31/16, A61K 38/12, C07K 7/56
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Status:
Request for examination was made
EP16736161

VACCINE AGAINST RSV

IPC classification:
A61K 39/155
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Status:
Request for examination was made
EP16738112

STABILIZED SOLUBLE PRE-FUSION RSV F POLYPEPTIDES

IPC classification:
C07K 14/005, A61K 39/155
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Status:
Request for examination was made
EP16760463

STABILIZED VIRAL CLASS I FUSION PROTEINS

IPC classification:
C07K 2/00, A61K 39/21, A61K 39/145, A61K 39/12
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Status:
Request for examination was made
EP16788669

STRUCTURE BASED DESIGN OF D-PROTEIN LIGANDS

IPC classification:
G06F 19/00, G06F 19/18, G06F 19/16
Agent:
Annemieke Manten, Janssen Vaccines & Prevention B.V.
Status:
Request for examination was made

Please Sign in to use this feature